RFLNYSEPharmaceutical PreparationsFiscal year ends July 31

Rafael Holdings, Inc.

Financials through Q3 FY2026, quarter ended Apr 30, 2026Last filing: 10-Q on Jun 11, 2026

$1.29−0.10 (-7.19%)

Close on Oct 19, 2026

Market cap: $66.09M
P/E (TTM): –
Dividend yield: –

Rafael Holdings, Inc. income statement

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-07-31	FY 2024 2024-07-31	FY 2023 2023-07-31	FY 2022 2022-07-31	FY 2021 2021-07-31	FY 2020 2020-07-31	FY 2019 2019-07-31	FY 2018 2018-07-31	FY 2017 2017-07-31	FY 2016 2016-07-31
Revenue	0.92	0.64	0.28	0.41	0.80	4.91	4.93	4.37	5.62	5.59
Cost of Revenue	–	0.15	–	3.50	3.17	–	–	–	–	–
Gross Profit	–	0.48	–	-3.09	-2.37	–	–	–	–	–
Research & Development	13	4.17	6.31	8.74	4.91	2.39	1.03	1.00	–	–
Selling, General & Admin	–	–	–	17	17	9.12	8.82	5.52	3.73	2.75
General & Administrative	14	8.85	8.93	17	6.11	–	–	–	–	–
Operating Income	-29	-103	-15	-60	-28	-8.47	-6.70	-3.84	0.22	1.19
Interest Expense	0.66	0.25	–	0.01	0.01	0	–	–	–	–
Interest & Investment Income	2.00	2.38	3.25	0.20	0.00	–	0.04	–	–	–
Income from Equity Investments	–	-1.63	–	-0.58	0.38	0.19	–	-0.10	–	–
Other Non-Operating Income	0.31	0.12	–	–	–	–	–	–	–	–
Merger & Restructuring Charges	–	–	–	–	7.00	–	–	–	–	–
Asset Impairment Charges	3.05	–	–	–	7.00	4.00	–	–	–	–
Gain (Loss) on Investments	–	-1.63	–	–	–	–	0.33	0.01	–	–
Gain (Loss) on Sale of Assets	-0.08	0.03	–	–	–	–	–	-0.01	–	–
Pretax Income	-33	-67	-8.75	-140	-23	-6.92	-4.94	-3.64	0.20	1.16
Income Tax Expense	-2.55	-2.68	-0.26	–	0.02	0.03	-0.02	8.44	0.07	0.45
Income from Continuing Operations	–	-65	-8.69	-141	-23	–	–	–	–	–
Income from Discontinued Operations	–	–	6.48	-1.83	-1.71	–	–	–	–	–
Net Income incl. Noncontrolling Interests	-31	-65	-2.22	-142	-25	-11	-4.92	-12	0.14	0.71
Minority Interest in Earnings	-0.12	-31	-0.34	-18	-0.22	-0.34	-0.23	-0.43	–	–
Net Income	-31	-34	-1.88	-125	-23	-11	-4.69	-12	0.14	0.71
Net Income to Common	–	-34	-1.88	-125	-25	–	–	–	–	–
EPS (Basic)(per share)	-1.04	-1.45	-0.08	-6.31	-1.49	-0.66	-0.35	-0.93	0.01	0.06
EPS (Diluted)(per share)	-1.04	-1.45	-0.08	-6.31	-1.49	-0.66	-0.35	-0.93	0.01	0.06
Shares Outstanding (Basic, Weighted)(shares)	29	24	23	20	17	16	13	12	0.01	0.01
Shares Outstanding (Diluted, Weighted)(shares)	29	24	23	20	17	16	13	12	0.01	0.01
EBITDA	-29	-102	-15	-60	-28	-6.60	-4.92	-2.14	1.89	2.84
Net Interest Income	–	–	–	–	-0.10	-0.03	0.47	0.02	0.01	-0.02

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Apr 30, 2026

Profitability, TTM

Gross margin: –
Operating margin: -3717.2%
Net margin: -2117.2%
Return on equity, FY2025: -34.6%

Financial strength

Current ratio: 3.16
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 276.7%

Valuation

P/E ratio: –
Price to sales: 67.43
Price to book: 0.88
Dividend yield: –